Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ilan Bruchim & Haim Werner. (2013) Targeting IGF-1 signaling pathways in gynecologic malignancies. Expert Opinion on Therapeutic Targets 17:3, pages 307-320.
Read now
Read now
Piotr J Wysocki & Bogna Wierusz-Wysocka. (2010) Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin. Expert Review of Molecular Diagnostics 10:4, pages 509-519.
Read now
Read now
Articles from other publishers (56)
Wenpeng Cai, Yongfang Ma, Li Song, Niandie Cao, Jiafeng Gao, Shuping Zhou & Xiaolong Tang. (2023) IGF-1R down regulates the sensitivity of hepatocellular carcinoma to sorafenib through the PI3K / akt and RAS / raf / ERK signaling pathways. BMC Cancer 23:1.
Crossref
Crossref
Shadi Ghorbanzadeh, Navid Poor-Ghassem, Masoomeh Afsa, Mohsen Nikbakht & Kianoosh Malekzadeh. (2022) Long non-coding RNA NR2F2-AS1: its expanding oncogenic roles in tumor progression. Human Cell 35:5, pages 1355-1363.
Crossref
Crossref
Alexander Gähler, Denis I. Trufa, Mircea T. Chiriac, Patrick Tausche, Katja Hohenberger, Ann-Kathrin Brunst, Manfred Rauh, Carol I. Geppert, Ralf J. Rieker, Susanne Krammer, Anna Leberle, Markus F. Neurath, Horia Sirbu, Arndt Hartmann & Susetta Finotto. (2022) Glucose-Restricted Diet Regulates the Tumor Immune Microenvironment and Prevents Tumor Growth in Lung Adenocarcinoma. Frontiers in Oncology 12.
Crossref
Crossref
Fatemeh Meshkini, Nahid Ramezani‐Jolfaie, Saman Sargazi, Cain C.T. Clark & Sepideh Soltani. (2022)
The effects of lycopene supplementation on
insulin‐like
growth factor‐1 and
insulin‐like
growth factor binding proteins: A systematic review of randomized controlled trials
. Phytotherapy Research 36:4, pages 1633-1643.
Crossref
Crossref
Yi Fang, Chi Yang, Yao Lu, Lihui Wei, Jinyan Zhao, Lisha Lu & Jiumao Lin. (2022) Based on the Network Pharmacology to Investigate the Mechanism of Qingjie Fuzheng Granules against Colorectal Cancer. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-14.
Crossref
Crossref
Jingxin Xin, Wencong Cheng, Yongbing Yu, Juan Chen, Xinhuan Zhang & Shanshan Shao. (2022) Diosgenin From Dioscorea Nipponica Rhizoma Against Graves’ Disease—On Network Pharmacology and Experimental Evaluation. Frontiers in Pharmacology 12.
Crossref
Crossref
Anna Ianza, Marianna Sirico, Ottavia Bernocchi & Daniele Generali. (2021) Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Jaime Guevara-Aguirre, Camila Bautista, Carlos Torres, Gabriela Peña, Carolina Guevara, Cristina Palacios, Alexandra Guevara & Antonio W. D. Gavilanes. (2020) Insights from the clinical phenotype of subjects with Laron syndrome in Ecuador. Reviews in Endocrine and Metabolic Disorders 22:1, pages 59-70.
Crossref
Crossref
Chengli Lu, Zhiyuan Ma, Xiaoming Cheng, Huichao Wu, Biguang Tuo, Xuemei Liu & Taolang Li. (2020) Pathological role of ion channels and transporters in the development and progression of triple-negative breast cancer. Cancer Cell International 20:1.
Crossref
Crossref
Rive Sarfstein, Adva Yeheskel, Tali Sinai-Livne, Metsada Pasmanik-Chor & Haim Werner. (2020) Systems Analysis of Insulin and IGF1 Receptors Networks in Breast Cancer Cells Identifies Commonalities and Divergences in Expression Patterns. Frontiers in Endocrinology 11.
Crossref
Crossref
Tali Sinai-Livne, Metsada Pasmanik-Chor, Zoya Cohen, Ilan Tsarfaty, Haim Werner & Raanan Berger. (2020) Proteomic analysis of combined IGF1 receptor targeted therapy and chemotherapy identifies signatures associated with survival in breast cancer patients. Oncotarget 11:17, pages 1515-1530.
Crossref
Crossref
Dianshuang Xu, Bolin Wu, Xiaoju Li, Yunjiu Cheng, Dubo Chen, Yuefeng Fang, Qiu Du, Zhiyong Chen & Xiaodong Wang. (2019) Evaluation of the thyroid characteristics of patients with growth hormone-secreting adenomas. BMC Endocrine Disorders 19:1.
Crossref
Crossref
Sho Nakai, Shutaro Yamada, Hidetatsu Outani, Takaaki Nakai, Naohiro Yasuda, Hirokazu Mae, Yoshinori Imura, Toru Wakamatsu, Hironari Tamiya, Takaaki Tanaka, Kenichiro Hamada, Akiyoshi Tani, Akira Myoui, Nobuhito Araki, Takafumi Ueda, Hideki Yoshikawa, Satoshi Takenaka & Norifumi Naka. (2019) Establishment of a novel human CIC-DUX4 sarcoma cell line, Kitra-SRS, with autocrine IGF-1R activation and metastatic potential to the lungs. Scientific Reports 9:1.
Crossref
Crossref
Caitrin Crudden, Dawei Song, Sonia Cismas, Eric Trocmé, Sylvya Pasca, George A. Calin, Ada Girnita & Leonard Girnita. (2019) Below the Surface: IGF-1R Therapeutic Targeting and Its Endocytic Journey. Cells 8:10, pages 1223.
Crossref
Crossref
Guo‐shu Xu, Zi‐wei Li, Zhi‐Ping Huang, F. Charles Brunicardi, Fu Jia, Chao Song, Hai‐jian Zou & Rui‐fen Sun. (2019)
Retracted:
MiR‐497‐5p inhibits cell proliferation and metastasis in hepatocellular carcinoma by targeting insulin‐like growth factor 1
. Molecular Genetics & Genomic Medicine 7:10.
Crossref
Crossref
Carla Souza Pereira Sobral, Marcelo Magalhães & Manuel dos Santos Faria. 2019. Knowledges on Thyroid Cancer. Knowledges on Thyroid Cancer.
Haim Werner, Lena Lapkina-Gendler, Laris Achlaug, Karthik Nagaraj, Lina Somri, Danielle Yaron-Saminsky, Metsada Pasmanik-Chor, Rive Sarfstein, Zvi Laron & Shoshana Yakar. (2019) Genome-Wide Profiling of Laron Syndrome Patients Identifies Novel Cancer Protection Pathways. Cells 8:6, pages 596.
Crossref
Crossref
Lin Dong, Meirong Du & Qianzhou Lv. (2019) Picropodophyllin inhibits type I endometrial cancer cell proliferation via disruption of the PI3K/Akt pathway. Acta Biochimica et Biophysica Sinica 51:7, pages 753-760.
Crossref
Crossref
Xia Wu, Lu Gao, Xiaopeng Guo, Qiang Wang, Zihao Wang, Wei Lian, Wei Liu, Jian Sun & Bing Xing. (2018) GH, IGF-1, and Age Are Important Contributors to Thyroid Abnormalities in Patients with Acromegaly. International Journal of Endocrinology 2018, pages 1-8.
Crossref
Crossref
Jaime Guevara-Aguirre, Alexandra Guevara, Iván Palacios, Mónica Pérez, Patricio Prócel & Enrique Terán. (2017) GH and GHR signaling in human disease. Growth Hormone & IGF Research.
Crossref
Crossref
Tali Cohen-Sinai, Zoya Cohen, Haim Werner & Raanan Berger. (2017) Identification of BRCA1 As a Potential Biomarker for Insulin-Like Growth Factor-1 Receptor Targeted Therapy in Breast Cancer. Frontiers in Endocrinology 8.
Crossref
Crossref
Katherine C. Gates, Lindsey N. Goetzmann, Jeremy D. Cantlon, Kimberly M. Jeckel & Russell V. Anthony. (2017) Effect of proline rich 15-deficiency on trophoblast viability and survival. PLOS ONE 12:4, pages e0174976.
Crossref
Crossref
N. I. Solovyeva, T. A. Gureeva, O. S. Timoshenko, T. A. Moskvitina & E. V. Kugaevskaya. (2017) Furin as proprotein convertase and its role in normal and pathological biological processes. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry 11:2, pages 87-100.
Crossref
Crossref
Doerte Poburski, Christiane Leovsky, Josefine Barbara Boerner, Luisa Szimmtenings, Michael Ristow, Michael Glei & René Thierbach. (2016) Insulin-IGF signaling affects cell transformation in the BALB/c 3T3 cell model. Scientific Reports 6:1.
Crossref
Crossref
N.I. Solovyeva, T.A. Gureeva, O.S. Timoshenko, T.A. Moskvitina & E.V. Kugaevskaya. (2016) Furin as proprotein convertase and its role in normal and pathological biological processes. Biomeditsinskaya Khimiya 62:6, pages 609-621.
Crossref
Crossref
Haim Werner, Rive Sarfstein, Derek LeRoith & Ilan Bruchim. (2016) Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection Pathways. Frontiers in Oncology 6.
Crossref
Crossref
Xuefeng Jing, Takashi Sonoki, Masayasu Miyajima, Takahiro Sawada, Nanako Terada, Shigeki Takemura & Kazushige Sakaguchi. (2016)
EphA4‐deleted microenvironment regulates cancer development and leukemoid reaction of the isografted 4T1 murine breast cancer via reduction of an
IGF
1 signal
. Cancer Medicine 5:6, pages 1214-1227.
Crossref
Crossref
Gary K. Schwartz, Mark A. Dickson, Patricia M. LoRusso, Edward A. Sausville, Yoshimi Maekawa, Yasuo Watanabe, Naomi Kashima, Daisuke Nakashima & Shiro Akinaga. (2016)
Preclinical and first‐in‐human phase I studies of
KW
‐2450, an oral tyrosine kinase inhibitor with insulin‐like growth factor receptor‐1/insulin receptor selectivity
. Cancer Science 107:4, pages 499-506.
Crossref
Crossref
Anatoliy I. Yashin, Eric Stallard & Kenneth C. LandSvetlana V. Ukraintseva, Konstantin G. Arbeev, Igor Akushevich, Alexander M. Kulminski, Eric Stallard & Anatoliy I. Yashin. 2016. Biodemography of Aging. Biodemography of Aging
113
141
.
Teresita L. Briones, Julie Woods & Magdalena Wadowska. (2015) RETRACTED: Involvement of insulin-like growth factor-1 in chemotherapy-related cognitive impairment. Behavioural Brain Research 279, pages 112-122.
Crossref
Crossref
Rive Sarfstein & Haim Werner. 2015. Receptor Tyrosine Kinases: Family and Subfamilies. Receptor Tyrosine Kinases: Family and Subfamilies
297
320
.
Hao Hong, Tapas R. Nayak, Sixiang Shi, Stephen A. Graves, Brianne C. Fliss, Todd E. Barnhart & Weibo Cai. (2014) Generation and Screening of Monoclonal Antibodies for ImmunoPET Imaging of IGF1R in Prostate Cancer. Molecular Pharmaceutics 11:10, pages 3624-3630.
Crossref
Crossref
Connie Bitelman, Rive Sarfstein, Menahem Sarig, Zohar Attias-Geva, Ami Fishman, Haim Werner & Ilan Bruchim. (2013) IGF1R-directed targeted therapy enhances the cytotoxic effect of chemotherapy in endometrial cancer. Cancer Letters 335:1, pages 153-159.
Crossref
Crossref
Rive Sarfstein, Yael Friedman, Zohar Attias-Geva, Ami Fishman, Ilan Bruchim & Haim Werner. (2013) Metformin Downregulates the Insulin/IGF-I Signaling Pathway and Inhibits Different Uterine Serous Carcinoma (USC) Cells Proliferation and Migration in p53-Dependent or -Independent Manners. PLoS ONE 8:4, pages e61537.
Crossref
Crossref
Anna Orlova, Camilla Hofstr?m, Joanna Strand, Zohreh Varasteh, Mattias Sandstrom, Karl Andersson, Vladimir Tolmachev & Torbj?rn Gr?slund. (2012) [99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours. European Journal of Nuclear Medicine and Molecular Imaging 40:3, pages 439-449.
Crossref
Crossref
Haim Werner & Ilan Bruchim. (2012) IGF-1 and BRCA1 signalling pathways in familial cancer. The Lancet Oncology 13:12, pages e537-e544.
Crossref
Crossref
Zohar Attias-Geva, Itay Bentov, Dvora Kidron, Keren Amichay, Rive Sarfstein, Ami Fishman, Ilan Bruchim & Haim Werner. (2012) p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapy. European Journal of Cancer 48:10, pages 1570-1580.
Crossref
Crossref
Keren Amichay, Debora Kidron, Zohar Attias-Geva, Hagit Schayek, Rive Sarfstein, Ami Fishman, Haim Werner & Ilan Bruchim. (2012) BRCA1 is Expressed in Uterine Serous Carcinoma (USC) and Controls Insulin-Like Growth Factor I Receptor (IGF-IR) Gene Expression in USC Cell Lines. International Journal of Gynecological Cancer 22:5, pages 748-754.
Crossref
Crossref
H Werner. (2011) Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer. Oncogene 31:22, pages 2703-2714.
Crossref
Crossref
Maria Catherine Pietanza & Charles M. Rudin. (2012) Novel Therapeutic Approaches for Small Cell Lung Cancer: The Future has Arrived. Current Problems in Cancer 36:3, pages 156-173.
Crossref
Crossref
H. Christian Reinhardt & Bj?rn Schumacher. (2012) The p53 network: cellular and systemic DNA damage responses in aging and cancer. Trends in Genetics 28:3, pages 128-136.
Crossref
Crossref
Sheref E. Hassan, Mikhail Bekarev, Mimi Y. Kim, Juan Lin, Sajida Piperdi, Richard Gorlick & David S. Geller. (2011) Cell surface receptor expression patterns in osteosarcoma. Cancer 118:3, pages 740-749.
Crossref
Crossref
Rive Sarfstein, Metsada Pasmanik-Chor, Adva Yeheskel, Liat Edry, Noam Shomron, Naama Warman, Efrat Wertheimer, Sharon Maor, Lea Shochat & Haim Werner. (2012) Insulin-like Growth Factor-I Receptor (IGF-IR) Translocates to Nucleus and Autoregulates IGF-IR Gene Expression in Breast Cancer Cells. Journal of Biological Chemistry 287:4, pages 2766-2776.
Crossref
Crossref
Haim Werner, Zohar Attias-Geva, Itay Bentov, Rive Sarfstein, Hagit Schayek, Doron Weinstein & Ilan Bruchim. 2012. Insulin-like Growth Factors and Cancer. Insulin-like Growth Factors and Cancer
159
177
.
Jilong Yang, Antti Ylipää, Yan Sun, Hong Zheng, Kexin Chen, Matti Nykter, Jonathan Trent, Nancy Ratner, Dina C. Lev & Wei Zhang. (2011) Genomic and Molecular Characterization of Malignant Peripheral Nerve Sheath Tumor Identifies the IGF1R Pathway as a Primary Target for Treatment. Clinical Cancer Research 17:24, pages 7563-7573.
Crossref
Crossref
Takayuki Okano, Shouhong Xuan & Matthew W. Kelley. (2011) Insulin-Like Growth Factor Signaling Regulates the Timing of Sensory Cell Differentiation in the Mouse Cochlea. The Journal of Neuroscience 31:49, pages 18104-18118.
Crossref
Crossref
Chi-Ming Wu, Te-Mao Li, Sheng-Feng Hsu, Yi-Chang Su, Shung-Te Kao, Yi-Chin Fong & Chih-Hsin Tang. (2011) IGF-I enhances ?5?1 integrin expression and cell motility in human chondrosarcoma cells. Journal of Cellular Physiology 226:12, pages 3270-3277.
Crossref
Crossref
Zohar Attias-Geva, Itay Bentov, Dale L. Ludwig, Ami Fishman, Ilan Bruchim & Haim Werner. (2011) Insulin-like growth factor-I receptor (IGF-IR) targeting with monoclonal antibody cixutumumab (IMC-A12) inhibits IGF-I action in endometrial cancer cells. European Journal of Cancer 47:11, pages 1717-1726.
Crossref
Crossref
Zohar Attias-Geva, Itay Bentov, Ami Fishman, Haim Werner & Ilan Bruchim. (2011) Insulin-like growth factor-I receptor inhibition by specific tyrosine kinase inhibitor NVP-AEW541 in endometrioid and serous papillary endometrial cancer cell lines. Gynecologic Oncology 121:2, pages 383-389.
Crossref
Crossref
Ioannis Ilias, Thomas Paparrigopoulos, Elias Tzavellas, Dimitris Karaiskos, Panagiotis Kontoleon & Ioannis Liappas. (2011) IGF-I and IGFBP-3 before and after inpatient alcohol detoxification in alcohol-dependent subjects. Medical Science Monitor 17:10, pages CR547-CR551.
Crossref
Crossref
Ettore Capoluongo. (2011) Insulin-Like Growth Factor System and Sporadic Malignant Melanoma. The American Journal of Pathology 178:1, pages 26-31.
Crossref
Crossref
Shun Li, Shoshana Yakar & Pnina Brodt. 2011. Liver Metastasis: Biology and Clinical Management. Liver Metastasis: Biology and Clinical Management
233
271
.
Paolo A. Zucali, Iacopo Petrini, Elena Lorenzi, Maria Merino, Liang Cao, Luca Di Tommaso, Hye Seung Lee, Matteo Incarbone, Beatriz A. Walter, Matteo Simonelli, Massimo Roncalli, Armando Santoro & Giuseppe Giaccone. (2010) Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas. Cancer 116:20, pages 4686-4695.
Crossref
Crossref
William Engen, Terrence E. O’Brien, Brendan Kelly, Jacinda Do, Liezel Rillera, Lance K. Stapleton, Jack F. Youngren & Marc O. Anderson. (2010) Synthesis of aryl-heteroaryl ureas (AHUs) based on 4-aminoquinoline and their evaluation against the insulin-like growth factor receptor (IGF-1R). Bioorganic & Medicinal Chemistry 18:16, pages 5995-6005.
Crossref
Crossref
E. Witsch, M. Sela & Y. Yarden. (2010) Roles for Growth Factors in Cancer Progression. Physiology 25:2, pages 85-101.
Crossref
Crossref
Dara Cannata, Yvonne Fierz, Archana Vijayakumar & Derek LeRoith. (2010) Type 2 Diabetes and Cancer: What Is the Connection?. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 77:2, pages 197-213.
Crossref
Crossref